Literature DB >> 27591605

An ELISA method detecting the active form of suPAR.

Xiaolei Zhou1, Mingming Xu2, Hailong Huang3, Andrew Mazar4, Zafar Iqbal5, Cai Yuan6, Mingdong Huang7.   

Abstract

Urokinase plasminogen activator receptor (uPAR) exists in a number of formats in human plasma, including soluble uPAR (suPAR) and uPAR fragments. We developed an ELISA method to detect specifically the active form suPAR, which binds to its natural ligand uPA. The intra CV and inter CV of this ELISA assay is 8.5% and 9.6% respectively, and the assay can recover 99.74% of added recombinant suPAR from 10% plasma. This assay is quite sensitive, capable of detecting down to 15pg/ml of suPAR, and can measure suPAR concentrations in the range of 0.031-8ng/ml with high linear relationship. Plasma samples from pregnant women were also measured for the active form of suPAR with this assay, giving an averaged level of 1.39ng/ml, slightly higher than the level of pooled plasma from healthy donors (0.96ng/ml). This study demonstrates the feasibility to measure the active form of suPAR, which will likely have value in clinical applications.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Active suPAR; ELISA; Pregnant women; suPAR

Mesh:

Substances:

Year:  2016        PMID: 27591605     DOI: 10.1016/j.talanta.2016.07.004

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  3 in total

1.  Plasma levels of the active form of suPAR are associated with COVID-19 severity.

Authors:  Mingxiang Huang; Linlin Li; Jianshan Shen; Yao Wang; Rui Wang; Cai Yuan; Mingdong Huang; Longguang Jiang
Journal:  Crit Care       Date:  2020-12-29       Impact factor: 9.097

2.  Crystal structure and cellular functions of uPAR dimer.

Authors:  Shujuan Yu; Yaqun Sui; Jiawei Wang; Yongdong Li; Hanlin Li; Yingping Cao; Liqing Chen; Longguang Jiang; Cai Yuan; Mingdong Huang
Journal:  Nat Commun       Date:  2022-03-29       Impact factor: 14.919

Review 3.  Therapeutics targeting the fibrinolytic system.

Authors:  Haili Lin; Luning Xu; Shujuan Yu; Wanjin Hong; Mingdong Huang; Peng Xu
Journal:  Exp Mol Med       Date:  2020-03-09       Impact factor: 8.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.